1. Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension
   Seyeon Oh et al, 2021, Scientific Reports CrossRef
2. The stimulatory effects of eNOS/F92A-Cav1 on NO production and angiogenesis in BMSCs
   Peng Xia et al, 2016, Biomedicine & Pharmacotherapy CrossRef
3. From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling
   Rebecca L. Heise et al, 2016, Frontiers in Pediatrics CrossRef
4. Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats
   Jian-ying Chen et al, 2014, Acta Pharmacologica Sinica CrossRef
5. Efficacy of stem cell therapy for pulmonary arterial hypertension: a systematic review and meta-analysis of preclinical studies
   Xian-Fei Ding et al, 2019, Stem Cell Research & Therapy CrossRef
6. Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension
   Wei-Chun Huang et al, 2016, PLOS ONE CrossRef
7. Clopidogrel Enhances Mesenchymal Stem Cell Proliferation Following Periodontitis
   L.S. Coimbra et al, 2015, Journal of Dental Research CrossRef
8. Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity
   Rohan Varshney et al, 2016, Hypertension CrossRef
9. Stem/Progenitor Cells and Pulmonary Arterial Hypertension
   Xiangyuan Pu et al, 2021, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef
10. Vascular Repair and Regeneration as a Therapeutic Target for Pulmonary Arterial Hypertension
    Laszlo Farkas et al, 2013, Respiration CrossRef
11. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling
    Gesheng Cheng et al, 2017, Stem Cell Research & Therapy CrossRef
12. Transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) improves brain ischemia-induced pulmonary injury in rats associated to TNF-α expression
    Qin-qin He et al, 2016, Behavioral and Brain Functions CrossRef
13. Effects of bone marrow-derived mesenchymal stem cells transfected with survivin on pulmonary fibrosis in mice
    MI ZHOU et al, 2015, Experimental and Therapeutic Medicine CrossRef
14. Stem cell therapy in pulmonary hypertension: current practice and future opportunities
    Ruixuan Zheng et al, 2023, European Respiratory Review CrossRef
15. The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension
    Hyunsook Kang et al, 2015, Stem Cells and Development CrossRef
16. Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies
    Masafumi Fukumitsu et al, 2019, Journal of Cardiology CrossRef
17. Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism
    Mengzhi Wan et al, 2023, Respiratory Research CrossRef
18. Long-term research of stem cells in monocrotaline-induced pulmonary arterial hypertension
    Yun Luan et al, 2014, Clinical and Experimental Medicine CrossRef
19. Bone Marrow Mesenchymal Stem Cells Ameliorates Seawater-Exposure-Induced Acute Lung Injury by Inhibiting Autophagy in Lung Tissue
    Qiu-ping Liu et al, 2014, Pathology Research International CrossRef
20. Erythropoietin improves pulmonary hypertension by promoting the homing and differentiation of bone marrow mesenchymal stem cells in lung tissue
    Zhendong Zhong et al, 2023, Human Cell CrossRef